Companion animal arthritis market seen topping $7 billion by 2030

The Business Research Company says the global companion animal arthritis market will surpass $7 billion in 2030, driven by rising pet ownership, better diagnosis, and broader access to veterinary treatments. North America and the U.S. are expected to lead the market, while dogs remain the biggest segment.

Why it matters: - Companion animal arthritis is becoming a bigger slice of pet healthcare spending as owners seek treatment for chronic pain and mobility issues in aging pets. - The market’s growth signals more demand for veterinary diagnostics, pain management, supplements, and specialty care. - The report places the category at about 9% of the animal medicine market and nearly 2% of the broader veterinary healthcare industry by 2030.

What happened: - The Business Research Company published a 2026 market report on the global companion animal arthritis market. - The report projects the market will exceed $7 billion in 2030. - The market is forecast to grow at a 10% CAGR through 2030. - The report is available through a detailed market report. - A free sample report is also offered.

The details: - North America is expected to be the largest region in 2030, with a market value of $2.5 billion. - North America’s market is projected to rise from $1.6 billion in 2025 at a 10% CAGR. - The U.S. is expected to be the largest country in 2030, with a market value of $2.2 billion. - The U.S. market is projected to grow from $1.4 billion in 2025 at a 9% CAGR. - The dogs segment is expected to be the largest type segment, accounting for 59% of the market, or $4 billion, in 2030. - The market is segmented by type into dogs, cats, and other types. - The market is segmented by indication into osteoarthritis and inflammatory arthritis. - The market is segmented by treatment into medication, supplements, and other treatments. - The market is segmented by distribution channel into veterinary hospitals and clinics, retail pharmacies, online stores, and other channels. - Growth in North America is linked to rising pet ownership, more awareness of early diagnosis, higher veterinary spending, wider access to advanced therapeutics and supplements, and more focus on mobility and quality of life for aging pets. - U.S. growth is linked to a large aging companion-animal population, more pet insurance, strong specialty and rehabilitation networks, greater use of pain management and regenerative therapies, and continued investment in new treatment solutions. - The dogs segment is supported by higher osteoarthritis prevalence in large and aging breeds, more screening and diagnosis, rising demand for long-term pain management, growing use of therapeutic diets and joint supplements, and greater owner willingness to pay for advanced care. - The report says the dogs, cats, and other types segments together could add more than $3.3 billion in market value by 2030. - The dogs segment is projected to grow by $2 billion from 2025 to 2030, cats by $1 billion, and other types by $0.3 billion. - The report highlights three main growth drivers: growing awareness of animal health, advancements in veterinary pharmaceuticals, and higher pet healthcare spending. - Growing awareness of animal health is expected to add about 2.8% annual growth to the market. - Advancements in veterinary pharmaceuticals are projected to add about 2.5% annual growth. - Increasing pet healthcare spending is projected to add about 2.2% annual growth. - The 2026 report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future-trend analysis, and updated graphics and tables.

Between the lines: - The forecast points to a market moving from niche pet care into a more structured chronic-disease category. - The strongest growth themes are preventive care, longer treatment durations, and more willingness to pay for specialty veterinary services. - The report’s regional and segment breakdown suggests the biggest near-term opportunities are in mature pet markets, especially the U.S. and dog-focused treatments.

What's next: - The market is expected to keep expanding through 2030 as pet owners spend more on chronic care and mobility support. - Product developers and veterinary providers are likely to focus on pain relief, regenerative therapies, supplements, and long-term disease management. - The report frames dogs, cats, and other companion animals as the main growth pools over the next five years. - The Business Research Company says it continues to offer custom research services, including market entry research, competitor tracking, and supplier and distributor packages.

The bottom line: - Companion animal arthritis is emerging as a fast-growing veterinary category, with dogs and the U.S. driving much of the projected value through 2030.